Document is current
Any future updates will be listed below
-
Authors
Lowry, Gregory V. https://orcid.org/0000-0001-8599-008X
Giraldo, Juan Pablo https://orcid.org/0000-0002-8400-8944
Steinmetz, Nicole F.
Avellan, Astrid https://orcid.org/0000-0001-6081-4389
Demirer, Gozde S. https://orcid.org/0000-0002-3007-1489
Ristroph, Kurt D. https://orcid.org/0000-0002-6771-6105
Wang, Gerald J. https://orcid.org/0000-0002-0631-011X
Hendren, Christine O.
Alabi, Christopher A. https://orcid.org/0000-0003-2654-018X
Caparco, Adam
da Silva, Washington https://orcid.org/0000-0001-5558-286X
González-Gamboa, Ivonne https://orcid.org/0000-0003-1617-8252
Grieger, Khara D. https://orcid.org/0000-0002-0821-0534
Jeon, Su-Ji https://orcid.org/0000-0002-5917-8837
Khodakovskaya, Mariya V. https://orcid.org/0000-0001-6398-4105
Kohay, Hagay
Kumar, Vivek https://orcid.org/0000-0003-4737-3288
Muthuramalingam, Raja https://orcid.org/0000-0001-7471-918X
Poffenbarger, Hanna https://orcid.org/0000-0002-7715-373X
Santra, Swadeshmukul https://orcid.org/0000-0001-5929-5323
Tilton, Robert D.
White, Jason C. https://orcid.org/0000-0001-5001-8143
- License Information
-
More Information
Article History
Received: 22 October 2023
Accepted: 27 March 2024
First Online: 6 June 2024
Competing interests
: N.F.S. is a co-founder of, has equity in, and has a financial interest with Mosaic ImmunoEngineering Inc. N.S.F. is also a co-founder of, and serves as manager of Pokometz Scientific LLC, under which she is a paid consultant to Flagship Labs 95 Inc. and Arana Biosciences Inc. G.V.L. and J.P.G. received research funding from BASF for topics related to this review. The other authors declare no competing interests.
